Table 1 Immunophenotypic marker profiles of the original patient leukemia cells, CHH-1 cells and the tumor formed by CHH-1 cells.
| Â | Patient | CHH-1 | Tumor | Â | Patient | CHH-1 | Tumor |
|---|---|---|---|---|---|---|---|
CD34 | 79.93% | 53.40% | − | CD13 | − | − | − |
TdT | 89.12% | 98.80% | + | CD14 | − | − | N |
HLA-DR | 90.60% | 100.00% | N | CD15 | − | − | N |
CD10 | 87.16% | 67.50% | − | CD1α | − | − | − |
CD19 | 87.35% | 81.80% | + | CD16 | − | − | N |
CD79α | 90.10% | 99.00% | + | CD4 | − | N | − |
CD20 | 67.36% | 94.40% | + | CD8 | − | N | − |
CD38 | 86.00% | 99.80% | + | CD22 | N | 99.60% | + |
cyIgM | − | − | N | CD23 | N | 92.40% | + |
CD3 | − | − | − | Kappa | N | − | − |
CD2 | − | − | N | Lammda | N | − | − |
CD5 | − | − | − | c-myc | N | N | + |
CD7 | − | − | N | Bcl-2 | N | N | + |
CD138 | − | − | − | Bcl-6 | N | N | − |
CD56 | − | − | + | CD123 | N | N | − |
CD64 | − | − | N | CyclinD1 | N | N | − |
MPO | − | − | − | S100 | N | N | − |
CD117 | − | − | N | SOX11 | N | N | − |
CD33 | − | − | N | Ki-67 | N | N | >90% |
CD11c | − | − | N |  |  |  |  |
